Clinical trial
Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Anti-Viral Therapy
NCT00188240 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Anti-Viral Therapy
- Lead sponsor
- University Health Network, Toronto
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2003
- Completion date
- Not reported
- Enrollment
- 200
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.